Approval · Notice of Compliance 18040 · 2016
PUREGON: Notice of Compliance 18040
Issued April 29, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18040
- Date
- April 29, 2016
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Transfer of the manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PUREGON | Not yet assigned | — |
Medicinal ingredients
- FOLLITROPIN BETA 50 UNIT per 0.5ML
- FOLLITROPIN BETA 100 UNIT per 0.5ML